Archive ready

特殊免疫グロブリン製剤の供給体制整備事業の採択結果について|厚生労働省

https://www.mhlw.go.jp/stf/newpage_18476.html
April 3, 2026 at 09:31 PM JSTThe archive page, viewer, and downloads use this saved version.
April 3, 2026 at 09:31 PM JST·www.mhlw.go.jp

特殊免疫グロブリン製剤の供給体制整備事業の採択結果について|厚生労働省

Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.

StartedApril 3, 2026 at 09:31 PM JST

This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.

The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.

About this pageAI generated

This page is a press release from the Japanese Ministry of Health, Labour and Welfare dated May 11, 2021. It announces the selection results for the Special Immunoglobulin Product Supply System Improvement Project. Japan Pharmaceutical Co., Ltd. has been selected as the recipient of subsidies for establishing a supply system for special immunoglobulin preparations. The announcement was made by the Pharmaceutical and Living Health Bureau's Blood Policy Division. Detailed information is available in the attached PDF document.

特殊免疫グロブリン製剤の供給体制整備事業の採択結果について|厚生労働省 - Saved screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.